Literature DB >> 18219320

Mitochondrial complex III regulates hypoxic activation of HIF.

T Klimova1, N S Chandel.   

Abstract

Decreases in oxygen levels are observed in physiological processes, such as development, and pathological situations, such as tumorigenesis and ischemia. In the complete absence of oxygen (anoxia), mammalian cells are unable to generate sufficient energy for survival, so a mechanism for sensing a decrease in the oxygen level (hypoxia) before it reaches a critical point is crucial for the survival of the organism. In response to decreased oxygen levels, cells activate the transcription factors hypoxia-inducible factors (HIFs), which lead to metabolic adaptation to hypoxia, as well as to generate new vasculature to increase oxygen supply. How cells sense decreases in oxygen levels to regulate HIF activation has been hotly debated. Emerging evidence indicates that reactive oxygen species (ROS) generated by mitochondrial complex III are required for hypoxic activation of HIF. This review examines the current knowledge about the role of mitochondrial ROS in HIF activation, as well as implications of ROS-level regulation in pathological processes such as cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18219320     DOI: 10.1038/sj.cdd.4402307

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  147 in total

1.  Mammea E/BB, an isoprenylated dihydroxycoumarin protonophore that potently uncouples mitochondrial electron transport, disrupts hypoxic signaling in tumor cells.

Authors:  Lin Du; Fakhri Mahdi; Mika B Jekabsons; Dale G Nagle; Yu-Dong Zhou
Journal:  J Nat Prod       Date:  2010-10-07       Impact factor: 4.050

Review 2.  Role of reactive oxygen and nitrogen species in the vascular responses to inflammation.

Authors:  Peter R Kvietys; D Neil Granger
Journal:  Free Radic Biol Med       Date:  2011-11-12       Impact factor: 7.376

Review 3.  Mitochondrial regulation of cell cycle and proliferation.

Authors:  Valeria Gabriela Antico Arciuch; María Eugenia Elguero; Juan José Poderoso; María Cecilia Carreras
Journal:  Antioxid Redox Signal       Date:  2012-01-13       Impact factor: 8.401

Review 4.  Amyloid-β production: major link between oxidative stress and BACE1.

Authors:  Elena Tamagno; Michela Guglielmotto; Debora Monteleone; Massimo Tabaton
Journal:  Neurotox Res       Date:  2011-10-15       Impact factor: 3.911

5.  Antioxidant defense and oxidative damage vary widely among high-altitude residents.

Authors:  Allison J Janocha; Suzy A A Comhair; Buddha Basnyat; Maniraj Neupane; Amha Gebremedhin; Anam Khan; Kristin S Ricci; Renliang Zhang; Serpil C Erzurum; Cynthia M Beall
Journal:  Am J Hum Biol       Date:  2017-07-20       Impact factor: 1.937

6.  Quantitative Proteomics Analysis Reveals Novel Insights into Mechanisms of Action of Long Noncoding RNA Hox Transcript Antisense Intergenic RNA (HOTAIR) in HeLa Cells.

Authors:  Peng Zheng; Qian Xiong; Ying Wu; Ying Chen; Zhuo Chen; Joy Fleming; Ding Gao; Lijun Bi; Feng Ge
Journal:  Mol Cell Proteomics       Date:  2015-03-11       Impact factor: 5.911

Review 7.  Neuroprotective roles and mechanisms of neuroglobin.

Authors:  Zhanyang Yu; Xiang Fan; Eng H Lo; Xiaoying Wang
Journal:  Neurol Res       Date:  2009-03       Impact factor: 2.448

8.  Hypoxia-induced oxidative base modifications in the VEGF hypoxia-response element are associated with transcriptionally active nucleosomes.

Authors:  Mykhaylo V Ruchko; Olena M Gorodnya; Viktor M Pastukh; Brad M Swiger; Natavia S Middleton; Glenn L Wilson; Mark N Gillespie
Journal:  Free Radic Biol Med       Date:  2008-10-18       Impact factor: 7.376

9.  Identification of pY654-β-catenin as a critical co-factor in hypoxia-inducible factor-1α signaling and tumor responses to hypoxia.

Authors:  Y Xi; Y Wei; B Sennino; A Ulsamer; I Kwan; A N Brumwell; K Tan; M K Aghi; D M McDonald; D M Jablons; H A Chapman
Journal:  Oncogene       Date:  2012-12-17       Impact factor: 9.867

10.  Targeted photoredox catalysis in cancer cells.

Authors:  Huaiyi Huang; Samya Banerjee; Kangqiang Qiu; Pingyu Zhang; Olivier Blacque; Thomas Malcomson; Martin J Paterson; Guy J Clarkson; Michael Staniforth; Vasilios G Stavros; Gilles Gasser; Hui Chao; Peter J Sadler
Journal:  Nat Chem       Date:  2019-09-23       Impact factor: 24.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.